CA45562-6 - 0x000000000000649E

Males & Females of Non-Childbearing Potential

Mountain

* Stipend may pay up to reflected amount.
Start Date: 
February 19, 2025 - 3:00pm
End Date: 
March 9, 2025 - 1:30pm

Study Details

Study Number: CA45562
Group Number: 6
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Long Term
Study Length: 7 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Tuesday 2/11/2025
Friday 2/14/2025
Monday 2/17/2025
Tuesday 2/18/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 2/11/2025
Friday 2/14/2025
Monday 2/17/2025
Tuesday 2/18/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 2/19/2025 3:00:00 PM 2/26/2025 9:30:00 AM 1 Lincoln
Phone participant Sunday 3/9/2025 1:30:00 PM 2 Lincoln